Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
funding
Biotech
Eikon blames US cuts for 15% staff reduction
Only three months after banking a $350 million series D, Eikon Therapeutics is blaming government cuts for its decision to lay off 15% of its employees.
James Waldron
May 22, 2025 7:55am
NIH terminated $1.8B in grants in 40 days under Trump: study
May 9, 2025 3:04am
'Too big and unfocused': Trump slashes NIH budget by $18B
May 2, 2025 2:42pm
Biohaven lands funding Oberland funding deal worth up to $600M
Apr 28, 2025 4:43pm
Cour inks $940M-plus autoimmune deal with Roche's Genentech
Dec 3, 2024 7:58am
Life science credit firm unveils with $600M
Aug 6, 2024 10:30am